Third-Line Rescue Therapy with Bismuth-Containing Quadruple Regimen After Failure of Two Treatments (with Clarithromycin and Levofloxacin) for H. pylori Infection
Authors:
- On behalf of the H. pylori Study Group of the Spanish Gastroenterology AssociationOAOn behalf of the H. pylori Study Group of the Spanish Gastroenterology Association
- J. P. GisbertJGJ. P. Gisbert
- L. RodrigoL. Rodrigo
- M. Castro-FernándezMCM. Castro-Fernández
- J. BarrioJBJ. Barrio
- 15 October 2013
- journal article
- clinical trial
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 59 (2) , 383-389
Abstract
Helicobacter pylori eradication therapy with a proton pump inhibitor (PPI), clarithromycin, and amoxicillin fails in >20 % of cases. A rescue therapy with PPI–amoxicillin–levofloxacin still fails in >20 % of patients.Keywords
This publication has 53 references indexed in Scilit:
- Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus ReportGut, 2012
- Rescue Therapy forHelicobacter pyloriInfection 2012Gastroenterology Research and Practice, 2012
- Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trialThe Lancet, 2011
- Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysisWiener klinische Wochenschrift, 2010
- Bismuth‐Containing Quadruple Therapy as Second‐Line Treatment for Helicobacter pylori Infection: Effect of Treatment Duration and Antibiotic Resistance on the Eradication Rate in KoreaHelicobacter, 2010
- Comparison of short- and long-term treatment protocols and the results of second-line quadruple therapy in children with Helicobacter pylori infectionJournal of Gastroenterology, 2008
- Comparison of three different second‐line quadruple therapies including bismuth subcitrate in Turkish patients with non‐ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14‐day standard first‐line therapyJournal of Gastroenterology and Hepatology, 2007
- Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infectionBMC Gastroenterology, 2007
- Systematic review and meta‐analysis: levofloxacin‐based rescue regimens after Helicobacter pylori treatment failureAlimentary Pharmacology & Therapeutics, 2005
- Microbiology (metabolism, physiology)Helicobacter, 2003